Simon Clark
Co-Founder at Complement Therapeutics | Tübingen, Baden-Württemberg, Germany
Simon Clark’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Honorary Professor at The University of Manchester in November 2019 - Present
Co-Founder at Complement Therapeutics in July 2021 - Present
Advisor at Forbion in January 2024 - Present
Research Professor at University of Tübingen in October 2019 - Present
Research Fellow at The University of Manchester in September 2013 - October 2019
Postdoctoral Researcher at The University of Manchester in November 2006 - August 2013
University of Oxford, D.Phil, October 2026
University of Aberdeen, BSc (Hons), October 1997 to October 2026
Complement Therapeutics GmbH (CTx) is a German-headquartered biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. Our lead investigational product (CTx001) is being evaluated as a potential gene therapy for GA, a leading cause of blindness. Additional programs will evaluate potential therapeutic opportunities in other complement-mediated conditions. The Company has subsidiaries in the UK (Complement Therapeutics Ltd) and in the USA (Complement Therapeutics Inc) as well as research laboratories in Stevenage, UK. About Geographic Atrophy Geographic Atrophy (GA) is a leading cause of blindness in the elderly and represents the advanced stage of dry age-related macular degeneration. It is characterised by the progressive degeneration of photoreceptors, retinal pigment epithelium, and choriocapillaris, resulting in irreversible vision loss. GA affects over 5 million people globally and remains a significant unmet clinical need.
Discover more about Complement Therapeutics
CEO and Co-founder at Complement Therapeutics Ltd
Chief Executive Officer at Complement Therapeutics
(Jan 2022 – Present)
Founding Member and VP Strategy & Corporate Development at Complement Therapeutics
VP Strategy & Corporate Development at Complement Therapeutics
(Feb 2026 – Present)
Ophthalmologist | Pharmaceutical physician | Aesthetic practitioner | Entrepreneur
VP, Clinical Science at Complement Therapeutics
(Dec 2025 – Present)
SVP Quality and Compliance at Complement Therapeutics
Consulting on clinical, quality and development activities to US and UK based companies; various indications and phases of development
Founding member @Complement Tx | Building companies
• Led cross-functional strategy and execution of CTx001, delivering FDA IND filing and clearance, as well as MHRA iCTA submission and approval, advancing the program into First-in-Human studies.
• Directed program governance through GPT and SLT leadership, integrating Non...
CTO Complement Therapeutics
Chief Technology Officer at Complement Therapeutics
(Dec 2023 – Present)
What is Simon J Clark email address?
Email Simon J Clark at [email protected] and [email protected]. This email is the most updated Simon J Clark's email found in 2026.
How to contact Simon J Clark?
To contact Simon J Clark send an email to [email protected] or [email protected]. (updated on November 05, 2025)
What company does Simon Clark work for?
Simon Clark works for Complement Therapeutics.
What is Simon Clark's role at Complement Therapeutics?
Simon Clark is Co-Founder
What industry does Simon Clark work in?
Simon Clark works in the Biotechnology industry.
